GLAXO PRICING CEFTIN COMPETITIVELY WITH LILLY's CECLOR; FDA APPROVES SECOND-GENERATION ORAL CEPHALOSPORIN ON DEC. 28; LAUNCH SCHEDULED FOR FEBRUARY